Research in animal models and patient tissues has identified a new molecular pathway in the liver that suggests a commonly used anti-rejection medication could be repurposed to treat certain liver cancers.
from Top Health News -- ScienceDaily http://bit.ly/2MK3wwq
No comments:
Post a Comment